178 related articles for article (PubMed ID: 33713459)
1. Identification of the metabolites of n-butylidenephthalide in rat and human liver microsomes by liquid chromatography-high-resolution mass spectrometry.
Lin H; Zhang X; Zhang X; Xia S
Biomed Chromatogr; 2021 Aug; 35(8):e5115. PubMed ID: 33713459
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the metabolite of AdipoRon in rat and human liver microsomes by ultra-high-performance liquid chromatography combined with Q-Exactive Orbitrap tandem mass spectrometry.
Ge Y; Yu Y; Zhang Y; Li X; Liu Q
Biomed Chromatogr; 2019 Nov; 33(11):e4645. PubMed ID: 31306503
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling of senkyunolide A and identification of its metabolites in hepatocytes by ultra-high-performance liquid chromatography combined with diode-array detector and high-resolution mass spectrometry.
Zhang H; Liu C; Wang M; Sui Y
Rapid Commun Mass Spectrom; 2020 Nov; 34(21):e8894. PubMed ID: 32663340
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the metabolites of rosmarinic acid in human liver microsomes using liquid chromatography combined with electrospray ionization tandem mass spectrometry.
Su J; Jia F; Lu J; Chen W; Sun H; Liu T; Wu X
Biomed Chromatogr; 2020 Apr; 34(4):e4806. PubMed ID: 32012312
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the in vitro metabolites of idelalisib in liver microsomes and interspecies comparison.
Chen CM; Wu WB; Chen JF; Chen Y
J Pharm Biomed Anal; 2019 Jan; 162():249-256. PubMed ID: 30268993
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the metabolites of TUG-891 in rat, dog, and human hepatocytes using ultra-high-performance liquid chromatography tandem mass spectrometry and nuclear magnetic resonance spectroscopy.
Shi Q; Liu Y; Liu C; Wang J
Rapid Commun Mass Spectrom; 2020 Jun; 34(11):e8766. PubMed ID: 32108961
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolites characterization of ponatinib in human liver microsomes using ultra-high performance liquid chromatography combined with Q-Exactive-Orbitrap tandem mass spectrometry.
Gao L; Xu Q; Liu Q; Lang X
Biomed Chromatogr; 2020 Jun; 34(6):e4819. PubMed ID: 32112427
[TBL] [Abstract][Full Text] [Related]
8. Rapid detection and structural characterization of methysticin metabolites generated from rat and human liver microsomes and hepatocytes using ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry.
Tuerxuntayi A; Tusun A; Tajiguli A
Rapid Commun Mass Spectrom; 2021 Dec; 35(24):e9208. PubMed ID: 34606659
[TBL] [Abstract][Full Text] [Related]
9. A high-resolution mass spectrometric method for identification and characterization of the in vitro metabolites of senkyunolide H.
Yan Y; Chen F; Zou H; Zhang P; Wu X; Lin M
Rapid Commun Mass Spectrom; 2022 Oct; 36(19):e9362. PubMed ID: 35881078
[TBL] [Abstract][Full Text] [Related]
10. Identification of the metabolite of ophiopogonanone A by liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li X; Yin D; Sun Y
Rapid Commun Mass Spectrom; 2022 Jun; 36(12):e9311. PubMed ID: 35557016
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of vesatolimod in rat, dog, and human liver microsomes: Metabolic stability assessment, metabolite identification, and interspecies comparison.
Li W; Zhang J; Wang Y; Hu F; Zhang Y
Drug Test Anal; 2019 Feb; 11(2):240-249. PubMed ID: 30129284
[TBL] [Abstract][Full Text] [Related]
12. Identification of metabolites of evobrutinib in rat and human hepatocytes by using ultra-high performance liquid chromatography coupled with diode array detector and Q Exactive Orbitrap tandem mass spectrometry.
Li Z; Zhang L; Yuan Y; Yang Z
Drug Test Anal; 2019 Jan; 11(1):129-139. PubMed ID: 30102849
[TBL] [Abstract][Full Text] [Related]
13. Detection and identification of imperatorin metabolites in rat, dog, monkey, and human liver microsomes by ultra-high-performance liquid chromatography combined with high-resolution mass spectrometry and Compound Discoverer software.
He F; Zeng F; Situ X; He R; Zheng W; Chen Y; Ou D; Chen Y
Biomed Chromatogr; 2023 Oct; 37(10):e5702. PubMed ID: 37455366
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the metabolites of sinomenine using liquid chromatography combined with benchtop Orbitrap mass spectrometry and nuclear magnetic resonance spectroscopy.
Fang K; Ren S; Zhang Q
Rapid Commun Mass Spectrom; 2024 Feb; 38(3):e9669. PubMed ID: 38211350
[TBL] [Abstract][Full Text] [Related]
15. Metabolic characterization of (±)-praeruptorin A in vitro and in vivo by high performance liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry.
Song YL; Jing WH; Yan R; Wang YT
J Pharm Biomed Anal; 2014 Mar; 90():98-110. PubMed ID: 24342524
[TBL] [Abstract][Full Text] [Related]
16. Disposition of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'- (methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)- 1H-pyrazole-5-carboxamide (DPC 423) by novel metabolic pathways. Characterization of unusual metabolites by liquid chromatography/mass spectrometry and NMR.
Mutlib AE; Shockcor J; Chen SY; Espina RJ; Pinto DJ; Orwat MJ; Prakash SR; Gan LS
Chem Res Toxicol; 2002 Jan; 15(1):48-62. PubMed ID: 11800597
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the metabolites of H3B-6545 in vitro and in vivo by using ultra-high performance liquid chromatography combined with electrospray ionization linear ion trap-orbitrap tandem mass spectrometry.
Zhang D; Hao X; Xu L; Yang Y; Zhao H
Biomed Chromatogr; 2020 Feb; 34(2):e4746. PubMed ID: 31725913
[TBL] [Abstract][Full Text] [Related]
18. Characterization and identification of the metabolites of dihydromethysticin by ultra-high-performance liquid chromatography orbitrap high-resolution mass spectrometry.
Cheng C; Zhao S; Gu YL; Pang J; Zhao Y
J Sep Sci; 2022 Aug; 45(15):2914-2923. PubMed ID: 35689602
[TBL] [Abstract][Full Text] [Related]
19. Metabolic profiling of synthetic cannabinoid 5F-ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra-high-performance liquid chromatography/high-resolution mass spectrometry.
Presley BC; Castaneto MS; Logan BK; Jansen-Varnum SA
Rapid Commun Mass Spectrom; 2020 Nov; 34(22):e8908. PubMed ID: 32710798
[TBL] [Abstract][Full Text] [Related]
20. Characterization of in vitro metabolites of TM-2, a potential antitumor drug, in rat, dog and human liver microsomes using liquid chromatography/tandem mass spectrometry.
Men L; Zhao Y; Lin H; Yang M; Liu H; Tang X; Yu Z
Rapid Commun Mass Spectrom; 2014 Oct; 28(20):2162-70. PubMed ID: 25178720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
